Article on BCL-2 as a Prognostic Marker

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-12-16-cor2
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

American Association for Cancer Research (AACR)

Related search

BCL-2 Is a Prognostic Marker and Its Silencing Inhibits Recurrence in Ameloblastomas

Oral Diseases
OtorhinolaryngologyDentistry
2019English

BCL-2 Family Members as Prognostic Indicators in AML

Hematology
Hematology
2002English

BCL-2 Protein as a Marker of Neuronal Immaturity in Postnatal Primate Brain

Journal of Neuroscience
Neuroscience
1998English

BCL-2 Expression as a Predictive Marker of Hormone-Refractory Prostate Cancer Treated With Taxane-Based Chemotherapy

Clinical Cancer Research
Cancer ResearchOncology
2006English

Eosinopenia as a Prognostic Marker in Patients With Peritonitis

ISRN Infectious Diseases
2013English

Expression Status of Cyclase‑associated Protein 2 as a Prognostic Marker for Human Breast Cancer

Oncology Reports
MedicineCancer ResearchOncology
2016English

Expression of RNA-binding Protein Musashi-2, as a Negative Prognostic Marker in Metastatic Colorectal Cancer.

Современные проблемы науки и образования (Modern Problems of Science and Education)
2019English

P53 Expression as a Prognostic Marker in Inflammatory Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2004English

Sialyl Tn as a Prognostic Marker in Epithelial Ovarian Cancer

British Journal of Cancer
Cancer ResearchOncology
1992English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy